Candida Infection Prophylaxis in Hematopoietic Stem Cell Transplant Recipients
📧 Sign up to get email alerts when something new happens for Candida Infection Prophylaxis in Hematopoietic Stem Cell Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-23FDA Approved: MICAFUNGIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Micafungin (Hikma Pharmaceuticals USA Inc.), leading to changes/updates approved for this antifu…
-
FDA approval · 2011-06-08FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., updating its labeling with indicatio…